Understanding Gynecologic Cancer Incidence: A Global Perspective on Trends and Outcomes
*Corresponding Author:Received Date: Jun 01, 2024 / Published Date: Jun 30, 2024
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Cervical cancer remains a significant global health challenge, especially in low- and middle-income countries where access to screening and vaccination may be limited. While the primary etiological factor in cervical cancer is the persistent infection with high-risk human papillomavirus (HPV), recent research has shed light on the roles that hormonal receptors-particularly estrogen and progesterone receptors (ER and PR)-may play in cervical cancer development and progression. Understanding these hormonal pathways offers new insights that could help refine treatment approaches and improve outcomes for patients with cervical cancer
